New York, NY -- (SBWIRE) -- 02/01/2014 -- To receive alerts before the crowd, please take 7 seconds to sign up for our Premium SMS Alerts. Grab your cell phone and text the word "PICKS" to "555888”.
StockMarketIntel.com issues a special report on the following stocks: Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX), Stryker Corporation (NYSE:SYK), Novadaq Technologies Inc. (NASDAQ:NVDQ), Novo Nordisk A/S (ADR) (NYSE:NVO)
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) declined -3.79%, trading on 1.57 million shares, to end the trade at $79.04. If we look at its trading history of the past 52 weeks, the share price suffered a low of $43.69 and was moved to the maximum level of $89.96. The stock changed hands in a range of $78.96 to $81.00, bringing its market capitalization to about $18.48 billion. Vertex Pharmaceuticals Incorporated (Vertex) is in the business of discovering, developing, manufacturing and commercializing small molecule drugs for the treatment of serious diseases. The Company’s two products are INCIVEK (telaprevir), which is approved for the treatment of patients with genotype 1 hepatitis C virus (HCV), infection, and KALYDECO (ivacaftor), which is approved in the United States for the treatment of patients six years of age and older with cystic fibrosis (CF), who have at least one copy of the G551D mutation in the cystic fibrosis transmembrane conductance regulator (CFTR), gene.
Has VRTX Found The Bottom and Ready To Move Up? Find Out Here
Stryker Corporation (NYSE:SYK) declined -0.69%, to complete the trading session at $77.60, with a total volume of 1.56 million shares. The stock, on average, trades on a volume of 1.53 million shares. In the past 52 weeks, the share price has not declined below $61.53 and above $79.24. It floated in a range of $76.94 to $77.85 during the last trading session, with a beta value of 0.89. Its market capitalization now moved to about $29.33 billion. Stryker Corporation (Stryker) is a medical technology company. Stryker offers a diverse array of medical technologies, including reconstructive, medical and surgical, and neurotechnology and spine products. The Company operates in three business segments: Reconstructive, MedSurg, and Neurotechnology and Spine.
Has SYK Found The Bottom And Ready To Gain Momentum? Find Out Here
Novadaq Technologies Inc. (NASDAQ:NVDQ) recorded a gain of 6.33% and was in a range of $19.05-$21.31 before closing at $20.49. The share price hit its 52-week low of $8.53 and $21.31 was the best price. The stock completed the day with a total volume of 1.55 million shares, versus an average volume of 352,743 shares. Novadaq Technologies Inc. develops and commercializes medical imaging and therapeutic devices for use in the operating room. The Company's imaging platform can be used to visualize blood vessels, nerves and the lymphatic system during surgical procedures.
Will NVDQ Continue To Move Higher? Find Out Here
Novo Nordisk A/S (ADR) (NYSE:NVO) added 3.23% yesterday, bringing its market capitalization around $105.35 billion. The total number of shares that changed hands during the session was 1.55 million shares, as compared to average trading volume of 1.49 million shares. The share price, after opening at $39.53, made a high of $39.79 and hovered above $39.42 to end the day at $39.67. Novo Nordisk A/S is a Denmark-based company engaged in the discovery, development, manufacturing and marketing of pharmaceutical products. The Company reports two business segments: Diabetes care and Biopharmaceuticals.
Why Should Investors Buy NVO After The Recent Gain? Just Go Here and Find Out
To receive alerts before the crowd, please take 7 seconds to sign up for our Premium SMS Alerts. Grab your cell phone and text the word "PICKS" to "555888”.
Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. The disclaimer is to be read and fully understood before using our site, or joining our email list.
Neither StockMarketIntel.com, nor its employees and affiliates are registered as investment advisors or broker/dealers in any jurisdiction whatsoever. Through use of this website viewing or using you agree to hold StockMarketIntel.com, its operators, owners, employees, and affiliates harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damage (monetary or otherwise), or injury (monetary or otherwise) that you may incur. The information contained herein is based on sources that we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. Readers should always do their own due diligence and consult a financial professional. StockMarketIntel.com encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the companies profiled, or is available from public sources and StockMarketIntel.com makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled company. Any opinions expressed on this website are statements of judgment as of the date of publication and are subject to change without further notice, and may not necessarily be reprinted in future publications or elsewhere.
Read Full disclaimer at: http://stockmarketintel.com/Disclaimer.htm
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)